Citation: Pya. Ding et al., EFFICACY AND SAFETY OF FLUVASTATIN IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS AND HYPERCHOLESTEROLEMIA, Atherosclerosis, 136, 1998, pp. 90-90
Citation: Ca. Hu et al., CLONING, CHARACTERIZATION AND EXPRESSION OF CDNAS ENCODING HUMAN D-1-PYRROLINE-5-CARBOXYLATE SYNTHASE, American journal of human genetics, 61(4), 1997, pp. 1003-1003
Authors:
LIN WW
HU CA
STEEL G
OBIE C
STEEL J
LUND J
REEVES R
RUTBERG J
GERAGHTY M
VALLE D
Citation: Ww. Lin et al., HUMAN AND MURINE GENOMES CONTAIN 2 PROLINE OXIDASE HOMOLOGS, ONE OF WHICH MAPS TO DIGEORGE VCFS REGION AND IS DEFICIENT IN THE PRO/RE/, American journal of human genetics, 61(4), 1997, pp. 1492-1492
Citation: Ca. Hu et al., TYPE-II HYPERPROLINEMIA - CLONING AND EXPRESSION IN YEAST OF CDNAS ENCODING HUMAN DELTA(1)-PYRROLINE-5-CARBOXYLATE (P5C) DEHYDROGENASE AND DELINEATION OF MUTATIONS RESPONSIBLE FOR TYPE-II HYPERPROLINEMIA (HP-II), Pediatric research, 39(4), 1996, pp. 860-860
Citation: Ca. Hu et al., CLONING, CHARACTERIZATION, AND EXPRESSION OF CDNAS ENCODING HUMAN DELTA(1)-PYRROLINE-5-CARBOXYLATE DEHYDROGENASE, The Journal of biological chemistry, 271(16), 1996, pp. 9795-9800
Citation: Ca. Hu et al., TYPE-II HYPERPROLINEMIA - CLONING AND EXPRESSION IN YEAST OF CDNAS ENCODING HUMAN DELTA(1)-PYRROLINE-5-CARBOXYLATE (P5C) DEHYDROGENASE, THEENZYME-DEFICIENT IN TYPE-II HYPERPROLINEMIA (HP-II), American journal of human genetics, 57(4), 1995, pp. 1030-1030
Authors:
KUO SW
HUANG WS
HU CA
LIAO WK
FUNG TC
WU SY
Citation: Sw. Kuo et al., EFFECT OF THYROXINE ADMINISTRATION ON SERUM THYROTROPIN RECEPTOR ANTIBODY AND THYROGLOBULIN LEVELS IN PATIENTS WITH GRAVES HYPERTHYROIDISM DURING ANTITHYROID DRUG-THERAPY, European journal of endocrinology, 131(2), 1994, pp. 125-130